Nevertheless, since CTCs are a minor fraction of cell population in the peripheral blood of cancer patients, both in terms of absolute (<10 cell/mL) and relative numbers compared to other blood cells (1 CTC per 106–107 leukocytes) [47], their use for the detection of EML4-ALK rearrangements must rely on highly efficient detection strategies. This evidence concerns the gene ALK and cancer.